Friday
Moneysupermarket.com (LON:MONY) announced that it expected revenues for the first half to rise about 5% to £71.5m to give EBITDA of about £18m compared to £18.6m last year.
Sig (LON:SHI) reported that first half sales were down 4% to £1,291m as a result of extreme weather and competitive pricing and is cautious for its prospects for the rest of the year.
Michael Page International Plc (LON:MPI) announced Q2 gross profits up 33% to £111.5m driven by the 70% of the business outside the UK.
Bodycote International (LON:BOY) reported a steady and broad based improvement in demand since the end of April. Revenue in H1 is expected to be 8% higher than last year. Although sales in the second half will be lower the Board now expects headline operating profit for the year to be significantly above the current range of forecasts.
Thursday
Hays (LON:HAS) reported that sales in the second quarter rose by 14%.
Henderson Group (LON:HGG) announced that it expects recurring profit for the first half to be about £48m, up from £27.1m last year.
The Board of Chloride Group (LON:CHLD) has agreed to recommend the cash offer from Emerson Electric.
Connaught (LON:CNT) announced some management changes and confirmed the delays and reductions in the Social Housing division but says the business continues to perform well and the outlook remains robust.
Man Group (LON:EMG) reported FUM at 30th June of $38.5b, down from $39.4b at the end of March.
Babcock International Group (LON:BAB) announced that the year has started well and trading is resilient. The acquisition of VT has received all necessary clearances.
Robert Wiseman Dairies Plc (LON:RWD) reported at its AGM that the year has started positively.
Associated British Foods (LON:ABF) announced a 14% increase in sales for the 40 weeks to 19th June.
Wednesday
Investec (plc) (LON:INVP) has received a number of expressions of interest in its Rensburg Fund Management subsidiary that currently manages £800m in six unit trusts.
Aveva Group (LON:AVV) reported that it continues to trade in line with the Board's expectations.
Dechra Pharmaceuticals (LON:DPH) announced that Group revenue is 5.3% ahead of the previous year, that…
